Cite
HARVARD Citation
Panopoulou, A. et al. (2023). Impact of Ultra High-risk Genetics on Real-world Outcomes of Transplant-eligible Multiple Myeloma Patients. HemaSphere. 7 (2), pp. e831-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Panopoulou, A. et al. (2023). Impact of Ultra High-risk Genetics on Real-world Outcomes of Transplant-eligible Multiple Myeloma Patients. HemaSphere. 7 (2), pp. e831-. [Online].